Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track LKFT with free AI briefings, catalyst countdowns, and dilution alerts.

LKFT · Lakefront Biotherapeutics NV

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$2.2B Cash on Hand
118.4mo Cash Runway
Follow LKFT by email Get an email when LKFT reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about LKFT, unsubscribe in one click. Privacy

📣 What LKFT Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

🧪 Trial & FDA Catalysts

📊 Drug Pipeline

DrugIndicationMost advanced trialStatus
Anti-Tumor Necrosis Factor Alpha Drug (Product) Rheumatoid Arthritis Phase 4 · NCT04985435 Recruiting
Filgotinib Rheumatoid Arthritis Phase 4 · NCT04985435 Recruiting
Methotrexate Rheumatoid Arthritis Phase 3 · NCT02889796 Completed
Ziritaxestat Idiopathic Pulmonary Fibrosis Phase 3 · NCT03733444 Terminated
GLPG3970 Primary Sjögren Syndrome Phase 2 · NCT04700280 Terminated
Cadefrecitinib Dermatomyositis Phase 2 · NCT05695950 Completed
GLPG1205 Idiopathic Pulmonary Fibrosis Phase 2 · NCT03725852 Completed
GLPG1972 Osteoarthritis Phase 2 · NCT03595618 Completed
GLPG2737 Autosomal Dominant Polycystic Kidney Disease Phase 2 · NCT04578548 Terminated
GLPG4399 oral suspension Healthy Phase 1 · NCT04653467 Completed
GLPG4716 Healthy Phase 1 · NCT04971746 Completed
OM336 Sjogrens Disease Phase 1 · NCT07229144 Recruiting
Pravastatin Rheumatoid Arthritis Phase 1 · NCT04608344 Completed
Rosuvastatin Rheumatoid Arthritis Phase 1 · NCT04608344 Completed
[14]GLPG3970 oral solution Healthy Phase 1 · NCT04907149 Completed
GLPG4399 capsules Healthy Phase 1 · NCT04653467 Completed

Also used in these trials (approved or third-party drugs, not LKFT's own candidates): Adalimumab, Prednisone, Itraconazole, Midazolam Hydrochloride, Sulfasalazine, Nintedanib, Pirfenidone.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

LKFT holds $2.2B in cash and short-term investments and burns about $56.7M/quarter from operations, an estimated runway of 118.4 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 0 · Low

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LKFT files for a raise →

👥 Who Owns LKFT

Insiders Form 4 data not loaded yet Other 5%+ holders 37.3% Institutions (108 holders) 24.1% Public and other holders 38.6%
HolderTypeShares% of sharesAs of
Gilead Sciences, Inc. 5%+ holder (13D) 20,981,010 31.84% 2025-01-07
EcoR1 Capital, LLC Institution (13G, 5%+) 8,714,522 13.22% 2025-07-24
Madison Avenue International LP 5%+ holder (13G) 3,606,203 5.47% 2026-06-15

Share count 65,897,071 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full LKFT picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LKFT and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.